"In re Facebook, Inc. Securities Litigation"

District Court, N.D. California·Decided December 20, 2021·No. 5:18-cv-01725·Unknown

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 SAN JOSE DIVISION 7 8 IN RE Case No. 5:18-cv-01725-EJD FACEBOOK, INC. SECURITIES 9 LITIGATION ORDER GRANTING DEFENDANTS’ MOTION TO DISMISS THIRD 10 AMENDED COMPLAINT WITHOUT LEAVE TO AMEND 11 Re: Dkt. No. 145 12

13 Before the Court is Defendants’ motion to dismiss Plaintiffs’ third amended complaint. 14 Plaintiffs are person who purchased shares of Facebook common stock between February 3, 2017 15 and July 25, 2018 (“the Class Period”), who believe that Defendant Facebook, Inc. and Executive 16 Defendants Mark Zuckerberg, Sheryl K. Sandberg, and David W. Wehner made materially false 17 and misleading statements and omissions in connection with the purchase and sale of Facebook 18 stock. See Third Amended Complaint (“TAC”) ¶ 1, Dkt. No. 142. Plaintiffs allege that 19 Defendants violated Section 10(b), 20(a), and 20A of the Securities Exchange Act of 1934 (the 20 “Exchange Act”) and Rule 10b5 promulgated thereunder because Defendants made guarantees 21 that users had control over the sharing of their user data, while knowing that to not be true because 22 of the Cambridge Analytica data breach and the practice of “whitelisting” certain applications. 23 TAC ¶ 1 (focusing on Defendants’ statements and omissions concerning Facebook’s “privacy and 24 data protection practices”). 25 Defendants have filed a motion to dismiss, arguing that Plaintiffs have failed for a third 26 time to meet Federal Rule of Civil Procedure 9(b)’s heightened pleading requirements for 27 Case No.: 5:18-cv-01725-EJD 1 securities fraud. The Court agrees. Plaintiffs have failed to remedy the problems identified by the 2 Court in its prior dismissal order. See Order Granting Defendants’ Motion to Dismiss with Leave 3 to Amend (“August 2020 Order”), Dkt. No. 137. The Court therefore GRANTS Defendants’ 4 motion to dismiss without leave to amend. 5 I. BACKGROUND 6 Rather than repeat the background of this case for a third time, the Court refers the Parties 7 to its prior orders. To the extent the Parties ask the Court to alter its previous rulings, the Court 8 declines and AFFIRMS those rulings herein. 9 On October 15, 2018, Plaintiffs filed their Consolidated Class Action Complaint. See Dkt. 10 No. 86. On September 25, 2019, this Court granted Defendants’ motion to dismiss the 11 consolidated complaint after finding that Plaintiffs had failed to carry their burden to plead falsity 12 and scienter. The Court did not address reliance or loss causation in that order. Order Granting 13 Defendants’ Motion to Dismiss, Dkt. No. 118. 14 Plaintiffs filed their second amended complaint on November 15, 2019. See Dkt. No. 123 15 (“SAC”). On August 7, 2020, this Court again granted Defendants’ motion to dismiss the 16 complaint after finding that Plaintiffs failed to carry their burden to plead falsity, scienter, and loss 17 causation. August 2020 Order. This Court gave Plaintiffs one last opportunity to cure the 18 deficiencies identified by the Court. 19 On October 16, 2020, Plaintiffs filed their third amended complaint. Defendants moved to 20 dismiss the third amended complaint on December 18, 2020. Motion to Dismiss Third Amended 21 Class Action Complaint (“Mot.”), Dkt. No. 145. Plaintiffs filed an opposition. Lead Plaintiffs’ 22 Memorandum of Points and Authorities in Opposition (“Opp.”), Dkt. No. 153. Defendants then 23 filed a reply. Reply in Support of Defendants’ Motion to Dismiss (“Reply”), Dkt. No. 158. On 24 September 30, 2021, this Court granted Defendants’ motion to strike portions of Plaintiffs’ third 25 amended complaint. See Dkt. No. 166. Pursuant to that order, this Court will not consider Dr. 26 Cain’s opinions set forth in paragraphs 722 through 724 of the TAC and any other portions of the 27 Case No.: 5:18-cv-01725-EJD 1 TAC that rely on those opinions. 2 II. DISCUSSION 3 A. Legal Standard 4 To survive a Rule 12(b)(6) motion to dismiss, a complaint must contain sufficient factual 5 matter to “state a claim to relief that is plausible on its face.” Ashcroft v. Iqbal, 556 U.S. 662, 678 6 (2009); Fed. R. Civ. Pro. 8(a). Threadbare recitals of the elements of a cause of action supported 7 by mere conclusory statements do not suffice. Ashcroft, 556 U.S. at 678. 8 To show securities fraud under Section 10(b) and Rule 10b-5, plaintiffs must allege facts 9 sufficient to establish (1) a material misrepresentation or omission, (2) made with scienter, i.e., a 10 wrongful state of mind, (3) a connection between the misrepresentation and the purchase or sale of 11 a security; (4) reliance upon the misrepresentation; (5) economic loss; and (6) loss causation. 12 Loos v. Immersion Corp., 762 F.3d 880 (9th Cir. 2014), amended (Sept. 11, 2014). “To determine 13 whether a private securities fraud complaint can survive a motion to dismiss for failure to state a 14 claim, the court must determine whether particular facts in the complaint, taken as a whole, raise a 15 strong inference that defendants intentionally or with deliberate recklessness made false or 16 misleading statements to investors.” In re LeapFrog Enter., Inc. Sec. Litig., 527 F. Supp. 2d 1033, 17 1039–40 (N.D. Cal. 2007). 18 The pleading standard in securities fraud cases is heightened. Complaints alleging 19 securities fraud must meet the plausibility standard, the Private Securities Litigation Reform Act 20 (“PSLRA”), and Federal Rule of Civil Procedure 9(b)’s higher pleading standard. See Tellabs, 21 Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308, 319–22 (2007); Zucco Partners, LLC v. 22 Digimarc, Corp., 552 F.3d 981, 991 (9th Cir. 2009). The PSLRA mandates that securities fraud 23 complaints (1) specify each misleading statement, (2) set forth the facts “‘on which [a] belief’” 24 that a statement was misleading was “‘formed,’” (3) and “state with particularity facts giving rise 25 to a strong inference that the defendant acted with the required state of mind [i.e., scienter].” Dura 26 Pharm., Inc. v. Broudo, 544 U.S. 336, 345 (2005) (quoting 15 U.S.C. §§ 78u–4(b)(1)–(2)). 27 Case No.: 5:18-cv-01725-EJD 1 Plaintiffs bear the burden of proving that the defendant’s misrepresentations “caused the loss for 2 which the plaintiff seeks to recover.” Id. In determining whether a “strong inference” of scienter 3 has been sufficiently alleged, this Court must not only draw “inferences urged by the plaintiff,” 4 but must also engage in a “comparative evaluation,” and examine and consider “competing 5 inferences [in defendants’ favor] drawn from the facts alleged.” Tellabs, 551 U.S. at 314. Hence, 6 scienter must not only be “plausible or reasonable,” it must also be “cogent or at least as 7 compelling as any opposing inference of nonfraudulent intent.” Id. at 324. Federal Rule of Civil 8 Procedure 9(b) further requires a plaintiff pleading securities fraud to state, with particularity, the 9 circumstances constituting fraud or mistake. 10 B. Defendants’ Motion to Dismiss 11 In their motion to dismiss, Defendants argue that Plaintiffs have not remedied the problems 12 identified by the Court in its earlier orders.

Free access — add to your briefcase to read the full text and ask questions with AI

"In re Facebook, Inc. Securities Litigation", (N.D. Cal. 2021).

"In re Facebook, Inc. Securities Litigation" ("In re Facebook, Inc. Securities Litigation") — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Dura Pharmaceuticals, Inc. v. Broudo
544 U.S. 336 (Supreme Court, 2005)
Tellabs, Inc. v. Makor Issues & Rights, Ltd.
551 U.S. 308 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Bercovitch v. Baldwin School, Inc.
191 F.3d 8 (First Circuit, 1999)
Neang Chea Taing v. Napolitano
567 F.3d 19 (First Circuit, 2009)
Lipton v. Pathogenesis Corp.
284 F.3d 1027 (Ninth Circuit, 2002)
Zucco Partners, LLC v. Digimarc Corp.
552 F.3d 981 (Ninth Circuit, 2009)
Metzler Investment GMBH v. Corinthian Colleges, Inc.
540 F.3d 1049 (Ninth Circuit, 2008)
Glazer Capital Management, LP v. Magistri
549 F.3d 736 (Ninth Circuit, 2008)
In Re Gilead Sciences Securities Litigation
536 F.3d 1049 (Ninth Circuit, 2008)
South Ferry LP, No. 2 v. Killinger
542 F.3d 776 (Ninth Circuit, 2008)
In Re Leapfrog Enterprises, Inc. Securities Litigation
527 F. Supp. 2d 1033 (N.D. California, 2007)
John Loos v. Immersion Corporation
762 F.3d 880 (Ninth Circuit, 2014)
Jacksonville Police & Fire Pf v. Cvb Financial Corp
811 F.3d 1200 (Ninth Circuit, 2016)
Carl Schwartz v. Arena Pharmaceuticals, Inc.
840 F.3d 698 (Ninth Circuit, 2016)
Daniela Prodanova v. H.C. Wainwright & Co.
993 F.3d 1097 (Ninth Circuit, 2021)